A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)
Clinical trial NCT05168904 · SUSPENDED
Trial details
- NCT number
- NCT05168904
- Sponsor
- Cyclacel Pharmaceuticals, Inc.
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-22
- Primary completion
- 2024-10-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.